IDEXX Laboratories (NASDAQ: IDXX) recently received a number of ratings updates from brokerages and research firms: 11/3/2026 – IDEXX Laboratories had its price target raised by UBS Group from $627.00 to $700.00. They now have a “neutral” rating on the stock. 11/3/2026 – IDEXX Laboratories had its price target raised by Morgan Stanley from $805.00 […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.